Summary4 min read

WSJ What’s News in Markets: CarMax Woes, Intel Soars, Tylenol Pressure

Date: September 27, 2025
Host: Jack Pitcher

Episode Overview

This episode delivers a concise recap of the biggest movers in the stock market for the week, digging into the economic headlines and company news shaping investor sentiment. Jack Pitcher highlights record-setting stock indices, the ongoing AI-fueled economic optimism, standout wins for Intel, struggles for CarMax, and a major controversy affecting Tylenol's parent company, Kinview.

Key Discussion Points and Insights

1. U.S. Market Recap: Strong Economic Data, Sputtering Indices

Indices Start Strong, End Soft:
- All three major stock indexes set record highs on Monday but lost steam as the week progressed.
- “Stocks opened hot this week when all three major indexes set records on Monday. But markets lost steam as the week went on…” (00:22)
Economic Fundamentals Remain Solid:
- Final GDP estimate for Q2 revised upward to 3.8% (from 3.3%).
- Weekly jobless claims dropped; durable goods orders bounced back.
- “All three data points back up the idea that the AI powered American economy is just fine and in fact is set to heat back up.” (00:39)
Valuation Skepticism:
- Concerns linger around pricey tech stocks and stress among lower income consumers.
- “Skeptics point out the historically expensive valuations for top tech stocks and signs of stress among lower income consumers.” (00:53)
Weekly Performance:
- S&P 500: down 0.3%
- Dow: down 0.1%
- Nasdaq: down 0.7%

2. Intel’s Remarkable Rebound and Partnerships

Major News and Surge:
- Intel approaches Apple and TSMC for partnerships, per WSJ report.
- Nvidia to invest $5 billion in Intel, deepening collaboration.
- “The good times keep rolling for Intel... That came after last week's news that Nvidia will invest $5 billion in intel as part of a new partnership.” (01:16)
Government Backing & Investor Reward:
- U.S. government recently took a 10% stake in Intel, boosting confidence.
- Since July’s decade-plus lows, Intel’s stock has nearly doubled.
- “Patient investors have been rewarded. Since hitting decade plus lows as recently as July, Intel's stock has almost doubled.” (01:31)
Performance Stats:
- Shares up 20% this week and 46% for September; best run since 1987.

3. CarMax’s Earnings Miss and Sector Red Flags

Massive Drop After Weak Quarter:
- CarMax posted sharply lower sales and profits amid falling used car demand.
- “CarMax, the biggest seller of used cars in the US posted dismal earnings on Thursday that sent its stock tanking.” (01:54)
Industry-Wide Implications:
- Q2 used car sales “crashing back to earth” after Q1 spike from tariff uncertainty.
- CEO acknowledged ongoing consumer distress.
- “CarMax's CEO told analysts the consumer has been distressed for a little while.” (02:07)
Market Impact:
- Shares fell 20% on Thursday; 23% for the week, hitting a five-year low.
- Broader concern for the “real economy that isn’t benefiting from huge spending on AI.” (02:16)

4. Tylenol Under Fire: Kinview’s Legal Headache

White House’s Stunning Statement:
- President Trump advised pregnant women not to take Tylenol, citing alleged autism links—sparking medical community backlash.
- “President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links.” (02:33)
Litigation Fears Intensify:
- Kinview bracing for a surge of new lawsuits.
- Has previously fought off claims, with a key case dismissed in 2023 for lack of evidence.
- “The drug maker has successfully fended off past lawsuits, including Most notably in 2023 when a federal judge ruled there wasn't sufficient evidence that Tylenol caused autism and dismissed lawsuits against Kinview.” (02:47)
Stock Reaction:
- Kinview shares lost over 10% this week; down 23% YTD.

Notable Quotes & Memorable Moments

On robust economic signals:
“All three data points back up the idea that the AI powered American economy is just fine and in fact is set to heat back up.” — Jack Pitcher (00:39)
On Intel’s extraordinary rally:
“Patient investors have been rewarded. Since hitting decade plus lows as recently as July, Intel's stock has almost doubled… Shares rose 20% this week and they're up 46% so far this month, on pace for their best performance since 1987.” — Jack Pitcher (01:31-01:38)
On consumer struggles hitting CarMax:
“CarMax's CEO told analysts the consumer has been distressed for a little while.” — Jack Pitcher (02:07)
On the Tylenol controversy shaking the sector:
“President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links.” — Jack Pitcher (02:33)

Timestamps for Key Segments

Market Recap & Economic Data: 00:14–01:05
Intel’s Surge & Partnerships: 01:10–01:45
CarMax Earnings & Autos Sector: 01:54–02:22
Tylenol, Kinview & Trump Statement: 02:26–02:59

Conclusion

Jack Pitcher’s wrap-up captures a market wrestling with both optimism and anxiety: ongoing records set to the tune of AI optimism, while fractures show up in traditional consumer sectors and healthcare. Investors basked in Intel’s resurgence, reeled from CarMax’s plunge, and braced for Tylenol’s looming legal storm. The episode provides a brisk, insightful rundown of the market’s pivotal events for the week.

Loading summary

Transcript3 lines

[00:01]
A
The US Forest Service is improving wildfire prediction models with Google AI. This is a new era of American innovation. Find out more at G CO AmericanInnovation.
[00:14]
B
Hey listeners, it's Saturday, September 27th. I'm Jack Pitcher for the Wall Street Journal and this is what's News in Markets, Our look at the biggest stock moves of the week and the news that drove them. Let's get to it. Stocks opened hot this week when all three major indexes set records on Monday. But markets lost steam as the week went on and not for any lack of good economic news. The government's final estimate of second quarter GDP growth came in at a strong 3.8% compared with a prior estimate of 3.3%. Meanwhile, weekly jobless claims showed a drop in the number of Americans who newly filed for unemployment and monthly durable goods orders bounced back. All three data points back up the idea that the AI powered American economy is just fine and in fact is set to heat back up. That's the very view that's pushed stocks to record after record in recent weeks. So what gives? Well, skeptics point out the historically expensive valuations for top tech stocks and signs of stress among lower income consumers. But for now, markets aren't all that phased. Finishing Friday just under records for the week, The S&P 500 dropped 0.3% while the Dow was 0.1% lower. The tech heavy Nasdaq fell 0.7%. The good times keep rolling for Intel. A Wall Street Journal report Thursday the chip maker has approached both Apple and Taiwan Semiconductor Manufacturing about partnerships sent the stock soaring. That came after last week's news that Nvidia will invest $5 billion in intel as part of a new partnership. Intel has notched a string of victories since the US government agreed to take a 10% stake in the long suffering chip maker. And so patient investors have been rewarded. Since hitting decade plus lows as recently as July, Intel's stock has almost doubled. Shares rose 20% this week and they're up 46% so far this month, on pace for their best performance since 1987. Of course, not everything is soaring. CarMax, the biggest seller of used cars in the US posted dismal earnings on Thursday that sent its stock tanking. Used car sales fell sharply in the second quarter, crashing back to earth following a first quarter spike that was fueled by higher demand due to uncertainty about tariffs. Sales and profits came in far below analyst estimates and CarMax's CEO told analysts the consumer has been distressed for a little while. The earnings were the latest point of concern for an auto industry that's had a tough 2025 and they're further evidence of a slowdown in the so called real economy that isn't benefiting from huge spending on AI. CarMax shares fell 20% Thursday to a five year low and they lost 23% for the week. The maker of Tylenol, Kinview, is continuing to struggle after an explosive White House news conference on Monday, President Trump warned the public that pregnant women should not take Tylenol due to its alleged links to autism. It was an event that stunned many of the nation's doctors and public health experts, some of whom dispute that there are any links. Kenview is now preparing for an explosion of litigation over its popular pain reliever. The drug maker has successfully fended off past lawsuits, including Most notably in 2023 when a federal judge ruled there wasn't sufficient evidence that Tylenol caused autism and dismissed lawsuits against Kinview. Shares of the company fell more than 10% this week and are down 23% for the year. And now you know what's news in markets this week. Today's show is produced by Rodney Davis with Deputy editor Chris Zensley. I'm Jack Pitcher. Have a great weekend and see you next Saturday.
[04:34]
C
At Janice Henderson Investors we believe working together is is the way to work better. Like combining your portfolio plans and our in depth strategy, your valued assets and our valuable insights, your vision and our mission working in harmony to seek the right investment opportunities. JANICE HENDERSON Investors Investing in a brighter future together.